BRIAN STEFAN: Open Payments
NPI 1427813021 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 39 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $159 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Lilly USA, LLC | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
| Novo Nordisk Inc | 5 | $89 |
| Exact Sciences Corporation | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 3 | $77 |
| Bausch Health US, LLC | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: XIFAXAN, JARDIANCE, FARXIGA, Cologuard Collection Kit, TZIELD, Wegovy, APLENZIN, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
